Browse by all authors Browse By Author ID - Hennig (Redmann), Stefanie

Browse Results (62 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

Page 1 of 2

Result Pages:    1 2  next › last »

Refine

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Hennig, S, Wainwright, C E, Bell, S, Miller, H, Charles, B G and Duffull, S B (2006). A D-optimal designed population pharmacokinetic study of itraconazole. In: Proceedings of the Australasian Pharmaceutical Science Association Annual Meeting. APSA Annual Meeting 2006, Adelaide, Australia, (74-74). 2-5 December 2006. 80  
Hennig, S., Wainwright, C. E., Bell, S., Miller, H., Charles, B. G. and Duffull, S. B. (2006). A D-optimal designed population pharmacokinetic study of itraconazole capsules and solution in adults with cystic fibrosis. In: PAGE: Abstracts of the Annual Meeting of the Population Approach Group in Europe. 15th Annual Meeting of the Population Approach Group in Europe, Bruges, Belgium, (). 14-16 June 2006. 141  
Hennig, Stefanie, Waterhouse, Timothy H., Bell, Scott C., France, Megan, Wainwright, Claire E., Miller, Hugh, Charles, Bruce G. and Duffull, Stephen B. (2007) A D-optimal designed population pharmacokinetic study of oral itraconazole in adult cystic fibrosis patients. British Journal of Clinical Pharmacology, 63 4: 438-450. doi:10.1111/j.1365-2125.2006.02778.x 171   28 Cited 29 times in Scopus29 3
Hennig, Stefanie, Ueckert, Sebastian, Nyberg, Joakim, Hooker, Andrew and Karlsson, Mats O. (2008). Application of optimal design for disease progression studies. In: Abstracts of PAGE 2008: 17th Meeting. PAGE 2008: Seventeenth Meeting, Marseille, France, (17-17). 18-20 June 2008. 37  
Nelis, Samantha, Kirkpatrick, Carl, Hennig, Stefanie, Nissen, Lisa and Shaw, Nick (2013). Application of population modelling to improve the estimation of drug withdrawal times in racehorses. In: 15th Annual Population Approach Group Australia and New Zealand Meeting (PAGANZ 2013), Brisbane, QLD, Australia, (). 13-15 February 2013. 30  
Hennig, Stefanie, Nyberg, Joakim, Fanta, Samuel, Backman, Janne T., Hoppu, Kalle, Hooker, Andrew C. and Karlsson, Mats O. (2011) Application of the optimal design approach to improve a pretransplant drug dose finding design for ciclosporin. Journal of Clinical Pharmacology, 52 3: 347-360. doi:10.1177/0091270010397731 41   6 Cited 5 times in Scopus5 0
Hennig, Stefanie, Nyberg, Joakim, Fanta, Samuel, Hooker, Andrew and Karlsson, Mats O. (2008). Application of the optimal design approach to improve therapeutic drug monitoring for cyclosporine. In: Abstracts of PAGE 2008: 17th Meeting. PAGE 2008: Seventeenth Meeting, Marseille, France, (17-17). 18-20 June 2008. 61  
Redmann, S. and Charles, B. G. (2006) A rapid HPLC method with fluorometric detection for determination of plasma itraconazole and hydroxyitraconazole concentrations in cystic fibrosis children with allergic bronchopulmonary aspergillosis. Biomedical Chromatography, 20 4: 343-348. doi:10.1002/bmc.569 304   11 Cited 15 times in Scopus15 0
Duffull, S. B., Waterhouse, T. H., Redmann, S. and Eccleston, J. A. (2004). A real time optimal design for model discrimination and parameter estimation for itraconazole population pharmacokinetics. In: Population Approach Group in Europe - Thirteenth Meeting. Population Approach Group in Europe - Thirteenth Meeting (PAGE 2004), Uppsala University, Sweden, (42-42). 17-18 June 2004. 75  
Lledo, Rocio, Hennig, Stefanie, Nyberg, Joakim, Hooker, Andrew C. and Karlsson, Mats O. (2008). A search for an ethically attractive dose-finding design for a drug with expected narrow therapeutic interval. In: PODE 2008: Population Optimum Design of Experiments. The third informal workshop on the theory of optimum experimental design for non-linear mixed effects models and applications in drug development, Paris, France, (). 23 June 2008. 28  
Sadhu, Geetapal, Mapp, Sally, Carrington, Christine and Hennig, Stefanie (2013). Can literature models describe the neutropenic time course produced by hyper-CVAD chemotherapy in non-Hodgkin lymphoma?. In: 15th Annual Population Approach Group Australia and New Zealand Meeting (PAGANZ 2013), Brisbane, QLD, Australia, (). 13-15 February 2013. 26  
Hennig, Stefanie, Friberg, Lena E. and Karlsson, Mats O. (2009). Characterizing time to conversion to sinus rhythm under digoxin and placebo in acute atrial fibrillation. In: Abstracts of the Annual Meeting of the Population Approach Group in Europe. 18th Annual Meeting of the Population Approach Group in Europe (PAGE), St Petersburg RUSSIA, (18-18). 23-26 June 2009. 38  
Hennig, Stefanie, Teo, Beverly, Stiller, Franziska and Staatz, Christine (2014). Comparing dosage adjustment methods for once daily tobramycin in children with cystic fibrosis. In: PAGANZ 2014: 16th Annual Population Approach Group in Australia and New Zealand Meeting, Dunedin, New Zealand, (). 29-31 January, 2014. 70  
Lledo-Garcia, R, Hennig, S and Karlsson, MO (2009) Comparison of dose-finding designs for narrow-therapeutic-index drugs: Concentration-controlled vs. dose-controlled trials. Clinical Pharmacology and Therapeutics, 86 1: 62-69. doi:10.1038/clpt.2009.23 42   3 Cited 4 times in Scopus4 0
Hennig, Stefanie and Karlsson, Mats O. (2013). Concordance between criteria for covariate model building. In: 15th Annual Population Approach Group Australia and New Zealand Meeting (PAGANZ 2013), Brisbane, QLD, Australia, (). 13-15 February 2013. 30  
Hennig, Stefanie and Karlsson, Mats (2014) Concordance between criteria for covariate model building. Journal of Pharmacokinetics And Pharmacodynamics, 41 2: 109-125. doi:10.1007/s10928-014-9350-8 29   0 Cited 0 times in Scopus0 0
Hennig, Stefanie and Duffull, Stephen (2007). Different ways of incorporating data below the quantification limit in datasets for parameter estimation. In: PAGANZ 07: Population Approach Group in Australia and New Zealand, Singapore, (). 13-15 February 2007. 97  
Hennig, S. and Duffull, S B (2006). Different ways of incorporating data below the quantification limit in datasets for parameter estimation. In: Proceedings of the First PAGANZ PAGJA Joint Meeting (2006). Population Approach Group Australia and New Zealand and the Pn, The University of Queensland / Brisbane, (3-3). August 2006. 81  
Lledo-Garcia, Rocío, Hennig, Stefanie, Nyberg, Joakim, Hooker, Andrew C. and Karlsson, Mats O. (2012) Ethically attractive dose-finding designs for narrow therapeutic index drugs. Journal of Clinical Pharmacology, 52 1: 29-38. doi:10.1177/0091270010390041 66 3 0 Cited 1 times in Scopus1 0
Redmann, S. (2004). High tobramycin blood levels due to dermal contamination on fingers after inhalation of TOBI. In: Queensland State Branch Conference Society of Hospital Pharmacists of Australia, Toowoomba, Qld, Australia, (). July 2004. 20  
Størset, Elisabet, Staatz, Christine, Hennig, Stefanie, Bergmann, Troels K. and Holford, Nick (2013). Identification of continuous covariate relationships. In: 15th Annual Population Approach Group Australia and New Zealand Meeting (PAGANZ 2013), Brisbane, QLD, Australia, (). 13-15 February 2013. 23  
Lledó-García, Rocío, Hennig, Stefanie and Karlsson, Mats O. (2008). Impact of study design for characterising PKPD covariance and nonlinearity in exposure-dichotomous response relationships. In: Abstracts of the Annual Meeting of the Population Approach Group in Europe. 17th Annual Meeting of the Population Approach Group in Europe, Marseille, France, (17-17). 18-20 June 2008. 34  
Lledó-García, Rocío, Hennig, Stefanie and Karlsson, Mats O. (2008). Impact of study design for characterizing PKPD covariance and nonlinearity in exposure-dichotomous response relationships. In: Abstracts of the Annual Meeting of the Population Approach Group in Europe. 17th Annual Meeting of the Population Approach Group in Europe (PAGE), Marseille, France, (17-17). 18-20 June 2008. 30  
Størset, Elisabet, Holford, Nick, Hennig, Stefanie, Bergmann, Troels K., Bremer, Stein, Bergan, Sara, Åsberg, Anders, Midtvedt, Karsten and Staatz, Christine E. (2014) Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling. British Journal of Clinical Pharmacology, 78 3: 509-523. doi:10.1111/bcp.12361 27   0 Cited 0 times in Scopus0 0
Redmann, S (2005). Itraconazole in allergic bronchopulmonary aspergillosis. In: CF: People and Science. 6th Australian and New Zealand Cystic Fibrosis Conference. Abstracts. 6th Australian & New Zealand Cystic Fibrosis Conference 2005, Adelaide, SA, Australia, (). 20-23 August 2005. 43  
Redmann, S. and Charles, B. G. (2004). Markedly increased itraconazole (ICZ) plasma levels in cystic fibrosis (CF) patients after switching from capsules to oral solution - two case studies. In: Warwick P. Anderson, 8th World Conference on Clinical Pharmacology & Therapeutics 2004 - Abstracts. CPT2004, Brisbane, (107-107). 1-6 Aug 2004. 54  
Hennig, S., Karlsson, M. O. and McIlleron, H (2011). Meta-modelling of rifabutin. In: Annual PKPDia Workshop, Cape Town, South Africa, (). 18-19 January 2011. 26  
Redmann, S., Stacey, S., Champion, A., Charles, B. G., Mitchell, P. and Wainwright, C. E. (2005). Misleading high tobramycin blood concentrations due to dermal contamination on fingers after inhalation of nebulised tobramycin (TOBI). In: CF: People and Science - 6th Australian and New Zealand Cystic Fibrosis Conference. 6th Australian and New Zealand Cystic Fibrosis Conference, Adelaide, South Australia, (105). 20-23 August, 2005. 55  
Redmann, S., Stacey, S., Champion, A., Wainwright, C. E. and Mitchell, P. (2004). Misleading high tobramycin blood levels due to dermal contamination on fingers after inhalation of TOBI. In: Bridging the Great Divide. SHPA Qld Branch Conference, Toowoomba, (59-59). 16-18 July, 2004. 42  
Redmann, S, Wainwright, C, Stacey, S, Champion, A, Mitchell, P, Cheney, J and Charles, B (2005) Misleading high tobramycin plasma concentrations can be caused by skin contamination of fingerprick blood following inhalation of nebulized tobramycin (TOBI (R)) - A short report. Therapeutic Drug Monitoring, 27 2: 205-207. doi:10.1097/01.ftd.0000155341.16361.62 105   4 Cited 4 times in Scopus4 0
Redmann, S. (2005). Misleading high Tobramycin plasma concentrations due to dermal contamination on fingers after inhalation of nebulised Tobramycin (TOBI®).. In: CF: People and Science - 6th Australian and New Zealand Cystic Fibrosis Conference. 6th Australian and New Zealand Cystic Fibrosis Conference, Adelaide, Australia, (). 20-23 August 2005. 27  
Redmann, S., Stacey, S., Champion, A., Wainwright, C. E., Mitchell, P., Cheney, J. and Charles, B. G. (2004). Misleading high tobramycin plasma concentrations due to dermal contamination on fingers after inhalation of nebulised tobramycin (TOBI). In: Building a healthier future through research. 4th Annual Queensland Health and Medical Scientific Meeting, Brisbane, (264-264). 30 November - 1 December, 2004. 44  
Duffull, S. B., Eccleston, J. A., Redmann, S. and Waterhouse, T. H. (2004). Optimal design for model discrimination and estimation with multiple responses. In: International Biometric Conference and Australian Statistical Conference, Carins, (). 11-16 July 2004. 17  
Waterhouse, T. H., Redmann, S., Duffull, S. B. and Eccleston, J. A. (2005) Optimal design for model discrimination and parameter estimation for itraconazole population pharmacokinetics in cystic fibrosis patients. Journal of Pharmacokinetics And Pharmacodynamics, 32 3-4: 521-545. doi:10.1007/s10928-005-0026-2 64   27 Cited 27 times in Scopus27 0
Hennig, Stefanie, Hooker, Andrew and Nyberg, Joakim (2009). Optimal design for models with semi-parametric distributions. In: PAGE 2009: Eighteenth Meeting, St. Petersberg, Russia, (18-18). 23-26 June 2009. 44 1
Ueckert, Sebastian, Hennig, Stefanie, Nyberg, Joakim, Karlsson, Mats O. and Hooker, Andrew C. (2013) Optimizing disease progression study designs for drug effect discrimination. Journal of Pharmacokinetics and Pharmacodynamics, 40 5: 587-596. doi:10.1007/s10928-013-9331-3 25   0 Cited 0 times in Scopus0 0
Hennig, S, Wainwright, C E, Bell, S, Miller, H, Friberg, L. E. and Charles, B G (2006). Paediatric population pharmacokinetcis (popPK) of itraconazole (ITRA) and its active metabolite hydroxy-itraconazole in cystic fibrosis (CF) and bone marrow transplant patients (BMT). In: Proceedings of PAGANZ 06. PAGANZ 06 9th Annual Scientific Meeting, Auckland New Zealand / School of Medicine, (207-207). 7-9 February 2006. 59  
Hennig, S., Wainwright, C. E., Bell, S. C., Miller, H., Friberg, L. E. and Charles, B. G. (2006). Paediatric population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in cystic fibrosis and bone marrow transplant patients. In: PAGE: Abstracts of the Annual Meeting of the Population Approach Group Europe. Population Approach Group Europe: 15th Meeting, Bruges, Belgium, (). 14-16 June 2006. 127  
Hennig, Stefanie (2006). Paediatric population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in cystic fibrosis and bone marrow transplant patients (BMT). In: Proceedings of PAGANZ 06. PAGANZ 06 9th Annual Scientific Meeting, School of Medicine / Auckland New Zealand, (). 7-9 February 2006. 48  
Stefanie Hennig, Carl Kirkpatrick and Bruce Charles (2007). Pharmacokinetics in paediatric patients with cystic fibrosis. In: PKUK Conference 2007, Edinburgh, Scotland, United Kingdom, (). 14-16 November 2007. 65  
Johansson, Asa, Mayne, N., Hennig, S., Perisoglou, M., Whelan, J., Karlsson, M. O. and Standing, J. F. (2009). Pharmacokinetics of high-dose methotrexate in adults and children. In: Abstracts of the Annual Meeting of the Population Approach Group in Europe. 18th Annual Meeting of the Population Approach Group in Europe (PAGE), St Petersburg RUSSIA, (18-18). 23-26 June 2009. 37  
Williams, Angela, Hennig, Stefanie, Donovan, Tim and Charles, Bruce (2013). Pharmacokinetics of Phenobarbitone in neonates – a population model based on routine therapeutic drug monitoring data. In: 15th Annual Population Approach Group Australia and New Zealand Meeting (PAGANZ 2013), Brisbane, QLD, Australia, (). 13-15 February 2013. 23  
Hennig, S, Wainwright, C E, Bell, S, Miller, H, Friberg, L. E. and Charles, B G (2006). Pharmacokinetic study of itraconazole leads to new improved dosing regimens for paediatric cystic fibrosis and bone marrow transplant patients. In: Proceedings of the 6th Annual Health and Medical Research Conference of Queensland. The 6th Annual Health and Medical Research Conference of Queensland, Brisbane, Australia, (). 23-24 November 2006. 51  
Hennig, Stefanie (2012). Pharmacometrics methods to individualise dose. In: Joint ASCEPT-APSA 2012 Conference: Final Program and Abstract Book. Joint ASCEPT-APSA 2012 Conference, Sydney, Australia, (97-97). 2-5 December 2012. 21  
Putt, M. T., Udy, A. A., Jarrett, P., Martin, J., Hennig, S., Salmon, N., Lipman, J. and Roberts, J. A. (2013) Phenytoin loading doses in adult critical care patients: does current practice achieve adequate drug levels?. Anaesthesia and Intensive Care, 41 5: 602-609. 62   0 Cited 0 times in Scopus0
Nyberg, J., Hennig, S., Karlsson, M. O. and Hooker, A. (2008). PopED. In: Abstracts of the Annual Meeting of the Population Approach Group in Europe. Population Approach Group in Europe. 17th Annual Meeting of the Population Approach Group in Europe (PAGE), Marseille, France, (). 18-20 June 2008. 24  
Nyberg, Joakim, Ueckert, Sebastian, Strömberg, Eric A., Hennig, Stefanie, Karlsson, Mats O. and Hooker, Andrew C. (2012) PopED: an extended, parallelized, nonlinear mixed effects models optimal design tool. Computer Methods and Programs in Biomedicine, 108 2: 789-805. doi:10.1016/j.cmpb.2012.05.005 52 1 11 Cited 13 times in Scopus13 0
Hennig, Stefanie (2006). Population pharmacokinetics of itraconazole PhD Thesis, School of Pharmacy, The University of Queensland. 441 39
Hennig, S., Wainwright, C. E., Bell, S. C., Miller, H., Friberg, L. E. and Charles, B. G. (2006) Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients. Clinical Pharmacokinetics, 45 11: 1099-1114. doi:10.2165/00003088-200645110-00004 124   19 Cited 22 times in Scopus22 3
Hennig, Stefanie, Norris, Ross, Tu, Quyen Tu, van Breda, Karin, Riney, Kate, Foster, Kelly, Lister, Bruce and Charles, Bruce (2014) Population pharmacokinetics of Phenytoin in critically ill children. Journal of Clinical Pharmacology, . doi:10.1002/jcph.417 21   0

Page 1 of 2

Result Pages:    1 2  next › last »